Evolution of Immuno Onco
Evolution of I/O targeted therapies and expectations of cancer patients and physicians Over the past five years, antibodies have become the best-selling drugs in the pharmaceutical market, eight of th ...
Bluebird bio Receives EC Approval for SKYSONA™ for Early Cerebral Adrenoleukodystrophy (CALD)
Bluebird bio, Inc. today announced that The European Commission (EC) had approved SKYSONA™ (elivaldogene autotemcel, Lenti-D™), one-time gene therapy for the treatment of early Cerebral Adrenoleukodys ...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) – Press Release
According to Thelansis, the global Chemotherapy-Induced Peripheral Neuropathy (CIPN) in 8 MM countries is estimated to be USD ~2.6 BN in 2020, USD and USD 4.7 BN by the end of 2030 (10 years of market ...
Help your company shift to a digital culture
Suspendisse potenti nullam ac tortor vitae purus faucibus ornare suspendi sse. Et ultrices neque ornare aenean euismod elementum nisi quis eleifend. Neque egestas congue quisque egestas diam in arcu c ...
The ways I can help you
Suspendisse potenti nullam ac tortor vitae purus faucibus ornare suspendi sse. Et ultrices neque ornare aenean euismod elementum nisi quis eleifend. Neque egestas congue quisque egestas diam in arcu c ...
How much does business insurance cost?
Suspendisse potenti nullam ac tortor vitae purus faucibus ornare suspendi sse. Et ultrices neque ornare aenean euismod elementum nisi quis eleifend. Neque egestas congue quisque egestas diam in arcu c ...